BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21529193)

  • 1. Regression of recurrent glioblastoma infiltrating the brainstem after convection-enhanced delivery of nimustine hydrochloride.
    Saito R; Sonoda Y; Kumabe T; Nagamatsu K; Watanabe M; Tominaga T
    J Neurosurg Pediatr; 2011 May; 7(5):522-6. PubMed ID: 21529193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and feasibility of convection-enhanced delivery of nimustine hydrochloride co-infused with free gadolinium for real-time monitoring in the primate brain.
    Sugiyama S; Saito R; Nakamura T; Yamashita Y; Yokosawa M; Sonoda Y; Kumabe T; Watanabe M; Tominaga T
    Neurol Res; 2012 Jul; 34(6):581-7. PubMed ID: 22709625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of Recurrent Spinal Cord High-Grade Glioma After Convection-Enhanced Delivery of Nimustine Hydrochloride: Case Reports and Literature Review.
    Endo T; Inoue T; Sugiyama S; Saito R; Tominaga T
    Oper Neurosurg (Hagerstown); 2020 Apr; 18(4):451-459. PubMed ID: 31414134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACNU-cisplatin continuous infusion chemotherapy as salvage therapy for recurrent glioblastomas: phase II study.
    Gwak HS; Youn SM; Kwon AH; Lee SH; Kim JH; Rhee CH
    J Neurooncol; 2005 Nov; 75(2):173-80. PubMed ID: 16132508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of anaplastic changes in low-grade astrocytomas of childhood.
    Dirks PB; Jay V; Becker LE; Drake JM; Humphreys RP; Hoffman HJ; Rutka JT
    Neurosurgery; 1994 Jan; 34(1):68-78. PubMed ID: 8121571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of interferon-beta therapy for recurrent glioblastoma: a case report.
    Utsuki S; Oka H; Miyajima Y; Sato K; Shimizu S; Suzuki S; Fujii K
    Tumori; 2011; 97(1):119-22. PubMed ID: 21528675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration rather than dose defines the local brain toxicity of agents that are effectively distributed by convection-enhanced delivery.
    Zhang R; Saito R; Mano Y; Kanamori M; Sonoda Y; Kumabe T; Tominaga T
    J Neurosci Methods; 2014 Jan; 222():131-7. PubMed ID: 24269253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local convection-enhanced delivery of chemotherapeutic agent transiently opens blood-brain barrier and improves efficacy of systemic chemotherapy in intracranial xenograft tumor model.
    Nakamura T; Saito R; Sugiyama S; Sonoda Y; Kumabe T; Tominaga T
    Cancer Lett; 2011 Nov; 310(1):77-83. PubMed ID: 21763069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts.
    Sugiyama S; Yamashita Y; Kikuchi T; Sonoda Y; Kumabe T; Tominaga T
    Neurol Res; 2008 Nov; 30(9):960-7. PubMed ID: 18671903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival and complete response of a patient with recurrent diffuse intrinsic brain stem glioblastoma multiforme.
    Burzynski SR; Lewy RI; Weaver R; Janicki T; Jurida G; Khan M; Larisma CB; Paszkowiak J; Szymkowski B
    Integr Cancer Ther; 2004 Sep; 3(3):257-61. PubMed ID: 15312271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.
    Sewing AC; Caretti V; Lagerweij T; Schellen P; Jansen MH; van Vuurden DG; Idema S; Molthoff CF; Vandertop WP; Kaspers GJ; Noske DP; Hulleman E
    J Neurosci Methods; 2014 Dec; 238():88-94. PubMed ID: 25263805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Well differentiated astrocytoma occurring nine years after radiation therapy for medulloblastoma.
    Osumi AK; Mclendon RE; Tien RD; Friedman HS; Graham M; Hockenberger B; Halperin EC; Oakes WJ
    Clin Neuropathol; 1994; 13(5):281-5. PubMed ID: 7805312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.
    Sugiyama S; Yamashita Y; Kikuchi T; Saito R; Kumabe T; Tominaga T
    J Neurooncol; 2007 Mar; 82(1):41-7. PubMed ID: 17031554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.
    Lidar Z; Mardor Y; Jonas T; Pfeffer R; Faibel M; Nass D; Hadani M; Ram Z
    J Neurosurg; 2004 Mar; 100(3):472-9. PubMed ID: 15035283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.
    Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN
    J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.
    Glas M; Hundsberger T; Stuplich M; Wiewrodt D; Kurzwelly D; Nguyen-Huu B; Rasch K; Herrlinger U
    Oncology; 2009; 76(3):184-9. PubMed ID: 19218824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convection-enhanced delivery of a hydrophilic nitrosourea ameliorates deficits and suppresses tumor growth in experimental spinal cord glioma models.
    Ogita S; Endo T; Sugiyama S; Saito R; Inoue T; Sumiyoshi A; Nonaka H; Kawashima R; Sonoda Y; Tominaga T
    Acta Neurochir (Wien); 2017 May; 159(5):939-946. PubMed ID: 28247160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma.
    Barua NU; Hopkins K; Woolley M; O'Sullivan S; Harrison R; Edwards RJ; Bienemann AS; Wyatt MJ; Arshad A; Gill SS
    Drug Deliv; 2016; 23(1):167-73. PubMed ID: 24786643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
    Kochi M; Kuratsu J; Mihara Y; Takaki S; Seto H; Uemura S; Ushio Y
    Neurosurgery; 1993 Nov; 33(5):817-23. PubMed ID: 8264878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma occurring at the site of a previous medulloblastoma following a 5-year remission period.
    Martin SE; Brat DJ; Vance GH; Stohler R; Choi H; Douglas-Akinwande AC; Hattab EM
    Neuropathology; 2012 Oct; 32(5):543-50. PubMed ID: 22151431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.